BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6607297)

  • 21. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD; Qamar T; Redecha P; Harpel PC
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

  • 24. Human serum sickness.
    Lawley TJ; Bielory L; Gascon P; Yancey KB; Young NS; Frank MM
    Trans Assoc Am Physicians; 1984; 97():49-55. PubMed ID: 6336015
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi.
    Sinha D; Wells M; Faulk WP
    Clin Exp Immunol; 1984 Apr; 56(1):175-84. PubMed ID: 6370518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immune complexes and complement in leprosy (author's transl)].
    Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
    Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
    Tönnessen TI; Nyland H; Aarli JA
    Eur Neurol; 1982; 21(2):124-8. PubMed ID: 6920298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological and immunological evidence of coagulopathy in renal complications of pregnancy.
    Seymour AE; Petrucco OM; Clarkson AR; Haynes WD; Lawrence JR; Jackson B; Thompson AJ; Thomson NM
    Perspect Nephrol Hypertens; 1976; 5():139-53. PubMed ID: 63937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The modulation of immune complex aggregation by classical pathway-mediated reactions.
    Gronski P; Bodenbender L; Kanzy EJ; Loos M; Seiler FR
    Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
    Hoffmeister HM; Fuhrer G; Platten HP; Heller W
    Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1q-binding immune complexes and other immunological studies in children with pulmonary hemosiderosis.
    Blanco A; Solís P; Gómez S; Linares P; Sánchez Villares E
    Allergol Immunopathol (Madr); 1984; 12(1):37-44. PubMed ID: 6375320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
    Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
    Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement changes in falciparum malaria infection.
    Phanuphak P; Hanvanich M; Sakulramrung R; Moollaor P; Sitprija V; Phanthumkosol D
    Clin Exp Immunol; 1985 Mar; 59(3):571-6. PubMed ID: 3886219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
    Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on relationship between complement and blood coagulation system in toxemia of pregnancy (author's transl)].
    Takahashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):341-50. PubMed ID: 7069248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.